Welcome to the RegSmart team, Torbjörn Wärnheim!

You have been a part of the life science industry for more than 30 years, and are a familiar face to many of us. You also hold a PhD and are Associate Professor in Physical Chemistry at KTH in Stockholm.

Tell us, what is your background within life science?

I have been responsible for pharmaceutical development and R&D in both smaller and larger life science companies. I‘ve had  senior executive positions in e.g. Moberg Pharma, Fresenius Kabi and Olink Proteomics. I have also been closely involved in management decisions related to strategic aspects of product development and positioning. That includes many practical experiences of development challenges in the different steps of taking a product idea from the early stages to the market.

What are your specialist areas and strengths?

I am experienced from CMC regulatory development, such as writing expert reports, regulatory documentation in general, and I have participated in authority meetings, including the FDA. I really enjoy analyzing and understanding the scientific and technical issues within the development chain, and to find appropriate and pragmatic solutions to upcoming challenges. That is what triggers me!

As a senior consultant in drug development, what are you looking forward to at RegSmart?

To support customers in pharmaceutical product development, making sure that the regulatory aspects are included to move ahead with the projects. And to have fun along the way!


Torbjörn will be a great asset to the RegSmart drug development team. Most welcome!